PPPs are crucial in cancer research for several reasons:
Resource Sharing: PPPs enable the sharing of financial, technical, and human resources, which can be particularly beneficial in large-scale cancer studies. Innovation Acceleration: By combining the innovative capabilities of private companies with the extensive research infrastructure of public institutions, PPPs can accelerate the development of new therapies and diagnostics. Risk Mitigation: Sharing the financial and operational risks between public and private entities can make high-risk, high-reward cancer research projects more feasible. Regulatory Expertise: Partnerships with private companies can provide valuable insights into the regulatory landscape, facilitating faster approval and commercialization of new treatments.
